Eversept Partners as of March 31, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 59 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quality Care Properties | 9.6 | $20M | 1.0M | 19.43 | |
| R1 Rcm | 6.5 | $14M | 1.9M | 7.14 | |
| Radius Health | 5.8 | $12M | 334k | 35.94 | |
| Aerie Pharmaceuticals | 5.5 | $11M | 211k | 54.25 | |
| Ablynx Nv | 4.8 | $9.9M | 182k | 54.56 | |
| Spdr S&p 500 Etf Tr option | 4.7 | $9.7M | 600.00 | 16225.00 | |
| Avexis | 4.6 | $9.7M | 78k | 123.58 | |
| Alnylam Pharmaceuticals (ALNY) | 4.5 | $9.4M | 79k | 119.10 | |
| GlaxoSmithKline | 4.3 | $8.9M | 227k | 39.49 | |
| Arena Pharmaceuticals | 4.2 | $8.7M | 221k | 39.50 | |
| Ensign (ENSG) | 4.1 | $8.6M | 326k | 26.34 | |
| Zogenix | 3.9 | $8.2M | 205k | 40.05 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $7.3M | 45k | 162.98 | |
| Array BioPharma | 2.8 | $5.8M | 358k | 16.32 | |
| Sanofi-Aventis SA (SNY) | 2.6 | $5.5M | 138k | 40.08 | |
| Nevro (NVRO) | 2.5 | $5.3M | 61k | 86.67 | |
| Teligent | 2.5 | $5.2M | 1.6M | 3.36 | |
| Sage Therapeutics (SAGE) | 1.9 | $3.9M | 24k | 161.08 | |
| BioMarin Pharmaceutical (BMRN) | 1.8 | $3.7M | 46k | 81.07 | |
| Tesaro | 1.4 | $2.9M | 52k | 57.14 | |
| Abbott Laboratories (ABT) | 1.4 | $2.9M | 48k | 59.92 | |
| Argenx Se (ARGX) | 1.4 | $2.9M | 36k | 80.43 | |
| Tg Therapeutics (TGTX) | 1.0 | $2.1M | 150k | 14.20 | |
| Abiomed | 1.0 | $2.1M | 7.1k | 290.95 | |
| Myokardia | 1.0 | $2.1M | 42k | 48.81 | |
| Invacare Corporation | 0.8 | $1.7M | 100k | 17.40 | |
| Deciphera Pharmaceuticals | 0.8 | $1.7M | 85k | 20.04 | |
| Puma Biotechnology (PBYI) | 0.8 | $1.6M | 23k | 68.05 | |
| Ascendis Pharma A S (ASND) | 0.8 | $1.6M | 24k | 65.39 | |
| Caretrust Reit (CTRE) | 0.7 | $1.5M | 108k | 13.61 | |
| Anthem (ELV) | 0.6 | $1.3M | 6.0k | 219.67 | |
| Medicines Company | 0.6 | $1.3M | 39k | 32.94 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $1.1M | 65k | 16.91 | |
| Haemonetics Corporation (HAE) | 0.5 | $1.1M | 15k | 73.19 | |
| eHealth (EHTH) | 0.5 | $1.1M | 75k | 14.31 | |
| Centene Corporation (CNC) | 0.5 | $1.1M | 10k | 106.90 | |
| Epizyme | 0.5 | $1.0M | 57k | 17.75 | |
| Magellan Health Services | 0.5 | $994k | 9.3k | 107.09 | |
| Global Blood Therapeutics In | 0.4 | $860k | 18k | 48.31 | |
| Align Technology (ALGN) | 0.4 | $753k | 3.0k | 251.00 | |
| Amarin Corporation | 0.4 | $753k | 250k | 3.01 | |
| Iradimed (IRMD) | 0.3 | $735k | 51k | 14.40 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $711k | 149k | 4.77 | |
| Affimed Therapeutics B V | 0.3 | $716k | 387k | 1.85 | |
| Dynavax Technologies (DVAX) | 0.3 | $596k | 30k | 19.87 | |
| Arbutus Biopharma (ABUS) | 0.3 | $588k | 118k | 5.00 | |
| Albireo Pharma | 0.3 | $587k | 18k | 32.56 | |
| Melinta Therapeutics | 0.3 | $569k | 77k | 7.41 | |
| Foamix Pharmaceuticals | 0.3 | $552k | 108k | 5.13 | |
| Aquinox Pharmaceuticals | 0.2 | $450k | 32k | 14.07 | |
| Ophthotech | 0.2 | $409k | 149k | 2.74 | |
| Envision Healthcare | 0.2 | $366k | 9.5k | 38.45 | |
| Seaspine Holdings | 0.1 | $313k | 31k | 10.13 | |
| Axogen (AXGN) | 0.1 | $183k | 5.0k | 36.60 | |
| Dermira | 0.1 | $160k | 20k | 7.99 | |
| MiMedx (MDXG) | 0.1 | $103k | 480.00 | 214.58 | |
| Quotient | 0.0 | $50k | 11k | 4.76 | |
| Celgene Corp right 12/31/2011 | 0.0 | $2.0k | 6.0k | 0.33 | |
| Assembly Biosciences | 0.0 | $4.0k | 22.00 | 181.82 |
